Genome-wide CNV analysis in mouse induced pluripotent stem cells reveals dosage effect of pluripotent factors on genome integrity

BMC Genomics

Volumn 15, Issue 1, 2014, Pages

  Chen, Yulin ^a   Guo, Lin ^b   Chen, Jiekai ^b   Zhao, Xiangjie ^b   Zhou, Weichen ^a   Zhang, Cheng ^a   Wang, Jiucun ^a   Jin, Li ^a   Pei, Duanqing ^b   Zhang, Feng ^a  

^a FUDAN UNIVERSITY   (China)

^b GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

Author keywords

CNV; Genome integrity; Induced pluripotent stem cell; Reprogramming factor; Reprogramming kinetics

Indexed keywords

ANIMALS; CELL LINE; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; GENOME; GENOMIC INSTABILITY; INDUCED PLURIPOTENT STEM CELLS; MICE; NUCLEAR REPROGRAMMING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RETROVIRIDAE; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 84892903262     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-15-79     Document Type: Article

References (26)

1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126(4):663-676. 10.1016/j.cell.2006.07.024, 16904174.
2. Robinton DA, Daley GQ. The promise of induced pluripotent stem cells in research and therapy. Nature 2012, 481(7381):295-305. 10.1038/nature10761, 3652331, 22258608.
3. Buganim Y, Faddah DA, Jaenisch R. Mechanisms and models of somatic cell reprogramming. Nat Rev Genet 2013, 14(6):427-439. 10.1038/nrg3473, 23681063.
4. Yamanaka S. Induced pluripotent stem cells: past, present, and future. Cell Stem Cell 2012, 10(6):678-684. 10.1016/j.stem.2012.05.005, 22704507.
5. Ben-David U, Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer 2011, 11(4):268-277. 10.1038/nrc3034, 21390058.
6. Hussein SM, Batada NN, Vuoristo S, Ching RW, Autio R, Narva E, Ng S, Sourour M, Hamalainen R, Olsson C, et al. Copy number variation and selection during reprogramming to pluripotency. Nature 2011, 471(7336):58-62. 10.1038/nature09871, 21368824.
7. Quinlan AR, Boland MJ, Leibowitz ML, Shumilina S, Pehrson SM, Baldwin KK, Hall IM. Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming. Cell Stem Cell 2011, 9(4):366-373. 10.1016/j.stem.2011.07.018, 21982236.
8. Ben-David U, Benvenisty N. High prevalence of evolutionarily conserved and species-specific genomic aberrations in mouse pluripotent stem cells. Stem Cells 2012, 30(4):612-622. 10.1002/stem.1057, 22328490.
9. Mayshar Y, Ben-David U, Lavon N, Biancotti JC, Yakir B, Clark AT, Plath K, Lowry WE, Benvenisty N. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 2010, 7(4):521-531. 10.1016/j.stem.2010.07.017, 20887957.
10. Abyzov A, Mariani J, Palejev D, Zhang Y, Haney MS, Tomasini L, Ferrandino AF, Rosenberg Belmaker LA, Szekely A, Wilson M, et al. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature 2012, 492(7429):438-442. 10.1038/nature11629, 3532053, 23160490.
11. Zhang F, Gu W, Hurles ME, Lupski JR. Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet 2009, 10:451-481. 10.1146/annurev.genom.9.081307.164217, 19715442.
12. Pinto D, Darvishi K, Shi X, Rajan D, Rigler D, Fitzgerald T, Lionel AC, Thiruvahindrapuram B, Macdonald JR, Mills R, et al. Comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants. Nat Biotechnol 2011, 29(6):512-520. 10.1038/nbt.1852, 3270583, 21552272.
13. Tang YC, Amon A. Gene copy-number alterations: a cost-benefit analysis. Cell 2013, 152(3):394-405. 10.1016/j.cell.2012.11.043, 3641674, 23374337.
14. Hanna JH, Saha K, Jaenisch R. Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 2010, 143(4):508-525. 10.1016/j.cell.2010.10.008, 3032267, 21074044.
15. Chen J, Liu J, Chen Y, Yang J, Chen J, Liu H, Zhao X, Mo K, Song H, Guo L, et al. Rational optimization of reprogramming culture conditions for the generation of induced pluripotent stem cells with ultra-high efficiency and fast kinetics. Cell Res 2011, 21(6):884-894. 10.1038/cr.2011.51, 3203703, 21445094.
16. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, Yamanaka S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008, 26(1):101-106. 10.1038/nbt1374, 18059259.
17. Chen J, Liu J, Yang J, Chen Y, Chen J, Ni S, Song H, Zeng L, Ding K, Pei D. BMPs functionally replace Klf4 and support efficient reprogramming of mouse fibroblasts by Oct4 alone. Cell Res 2011, 21(1):205-212. 10.1038/cr.2010.172, 3193408, 21135873.
18. Wang Y, Chen J, Hu JL, Wei XX, Qin D, Gao J, Zhang L, Jiang J, Li JS, Liu J, et al. Reprogramming of mouse and human somatic cells by high-performance engineered factors. EMBO Rep 2011, 12(4):373-378. 10.1038/embor.2011.11, 3077243, 21399616.
19. Carey BW, Markoulaki S, Hanna JH, Faddah DA, Buganim Y, Kim J, Ganz K, Steine EJ, Cassady JP, Creyghton MP, et al. Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. Cell Stem Cell 2011, 9(6):588-598. 10.1016/j.stem.2011.11.003, 22136932.
20. Stadtfeld M, Apostolou E, Akutsu H, Fukuda A, Follett P, Natesan S, Kono T, Shioda T, Hochedlinger K. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 2010, 465(7295):175-181. 10.1038/nature09017, 20418860.
21. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448(7151):313-317. 10.1038/nature05934, 17554338.
22. Papp B, Plath K. Reprogramming to pluripotency: stepwise resetting of the epigenetic landscape. Cell Res 2011, 21(3):486-501. 10.1038/cr.2011.28, 3193418, 21321600.
23. Polo JM, Anderssen E, Walsh RM, Schwarz BA, Nefzger CM, Lim SM, Borkent M, Apostolou E, Alaei S, Cloutier J, et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 2012, 151(7):1617-1632. 10.1016/j.cell.2012.11.039, 3608203, 23260147.
24. Esch D, Vahokoski J, Groves MR, Pogenberg V, Cojocaru V, Vom Bruch H, Han D, Drexler HC, Arauzo-Bravo MJ, Ng CK, et al. A unique Oct4 interface is crucial for reprogramming to pluripotency. Nat Cell Biol 2013, 15(3):295-301. 10.1038/ncb2680, 23376973.
25. Wang T, Chen K, Zeng X, Yang J, Wu Y, Shi X, Qin B, Zeng L, Esteban MA, Pan G, et al. The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. Cell Stem Cell 2011, 9(6):575-587. 10.1016/j.stem.2011.10.005, 22100412.
26. Chen J, Liu H, Liu J, Qi J, Wei B, Yang J, Liang H, Chen Y, Chen J, Wu Y, et al. H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nat Genet 2013, 45(1):34-42.